Company · CIK 0001711754 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Inmune Bio, Inc. · INMB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 MForm 4 → | Jul 7, 7:01 am EDT | Scott JudaDirector | 14,801 | $1.40 | $20,721 | 86,404 | — | |
| Jul 2, 2026 MForm 4 → | Jul 7, 7:01 am EDT | Mark William LowdellChief Scientific Officer | 7,211 | $1.40 | $10,095 | 1,518,017 | — | |
| Jul 2, 2026 MForm 4 → | Jul 7, 7:00 am EDT | David J MossChief Executive Officer, Director | 9,014 | $1.40 | $12,620 | 1,294,883 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 AForm 4 → | Sep 23, 6:05 am EDT | Ronnie Duane ClarkDirector | 100,000 | — | — | 100,000 | — | late |
| Sep 15, 2026 AForm 4 → | Sep 17, 1:44 pm EDT | James SapirsteinDirector | 100,000 | — | — | 100,000 | — | |
| Jul 2, 2026 XForm 4 → | Jul 7, 7:01 am EDT | Scott JudaDirector | 14,801 | $0.125 | $1,850 | 14,802 | — | |
| Jul 2, 2026 XForm 4 → | Jul 7, 7:01 am EDT | Mark William LowdellChief Scientific Officer | 7,211 | $0.125 | $901 | 7,212 | — | |
| Jul 2, 2026 XForm 4 → | Jul 7, 7:00 am EDT | David J MossChief Executive Officer, Director | 9,014 | $0.125 | $1,127 | 9,014 | — |